Back to first-pass browser

First-pass extracted concept

gene-targeted therapy

Candidate: concept label1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The abstract describes gene-targeted therapy as a focused medicine approach that more accurately regulates the immune system in rheumatoid arthritis. It is framed as helping prevent joint destruction and disease progression.

Source 1DOIPubMed

Resources required

The abstract supports that its clinical use involves coordination between rheumatology and orthopedic surgery teams. No specific drug, device, or assay requirements are named in the provided text.

Source 1DOIPubMed

What problem it solves

It is presented as addressing chronic inflammation and progressive joint damage in rheumatoid arthritis. The paper also links it to delaying surgery until unavoidable.

Source 1DOIPubMed

What it does not solve

The abstract does not claim that gene-targeted therapy eliminates the need for surgery in all patients. It also does not provide evidence for specific operative outcomes or named therapy limitations.

Source 1DOIPubMed

Alternatives

The abstract contrasts newer focused medicine approaches with surgery as a later intervention when unavoidable. It does not name specific alternative drug classes in the provided source text.

Source 1DOIPubMed

Evidence Snippets

Gene-targeted therapy facilitates an accurate regulation of the immune system, ultimately preventing the destruction of joints.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1care model impactsupports2025Source 1DOIPubMed

These focused medicine techniques foster interdisciplinary cooperation between orthopedics and rheumatology and are associated with increased mobility and quality of life.

Quoted textsource-backed
These innovative techniques are based on the use of focused medicine and foster interdisciplinary cooperation of experts in orthopedics and rheumatology, which, in turn, increases the mobility of the patient and the overall quality of life.
Claim 2clinical decision impactsupports2025Source 1DOIPubMed

New interventions that prevent rheumatoid arthritis progression require orthopedic surgeons to reconsider the timing and method of surgery.

Quoted textsource-backed
The new interventions that prevent the progression of the disease require orthopedic surgeons to reconsider the time and method of conducting surgery.
Claim 3practice shiftsupports2025Source 1DOIPubMed

Clinical practice has shifted toward early and preventive interventions for joint pathology to delay surgery until unavoidable.

Quoted textsource-backed
There has been a current change in clinical practice to involve early and preventive interventions for joint pathology to delay the use of surgery until it is unavoidable.
Claim 4therapeutic effectsupports2025Source 1DOIPubMed

Gene-targeted therapy is described as enabling accurate immune regulation and preventing joint destruction in rheumatoid arthritis.

Quoted textsource-backed
Gene-targeted therapy facilitates an accurate regulation of the immune system, ultimately preventing the destruction of joints.